Assessing Thyroid Function in the Elderly

  • Mary H. Samuels
Part of the Thyroid Function Testing book series (ENDO, volume 28)


With aging, the normal thyroid gland has been reported to increase in size, although this is not consistent, and some studies show no changes in thyroid gland size or weight (reviewed in [1]). Other studies have reported increased rates of thyroid gland atrophy and fibrosis, although this may be due to underlying autoimmune thyroid disease in the population. Finally, thyroid nodules are much more common with aging, with nodules discovered by ultrasound in up to 50% of subjects over the age of 50 years [2].


Thyroid Nodule Subclinical Hypothyroidism Autoimmune Thyroid Disease Overt Hypothyroidism Subclinical Hyperthyroidism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hershman JM, Hassani S, Samuels MH. Thyroid diseases. In: Hazard WR, et al., eds. Principles of Geriatric Medicine and Gerontology. 6th ed. New York, NY: McGraw-Hill; 2008:1287-1304.Google Scholar
  2. 2.
    Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993;328:553-559.CrossRefPubMedGoogle Scholar
  3. 3.
    Samuels MH. Subclinical thyroid disease in the elderly. Thyroid. 1998;8:803-813.CrossRefPubMedGoogle Scholar
  4. 4.
    Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526-534.CrossRefPubMedGoogle Scholar
  5. 5.
    Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-499.CrossRefPubMedGoogle Scholar
  6. 6.
    Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxford). 1977;7:481-493.CrossRefGoogle Scholar
  7. 7.
    Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxford). 1995;43:55-68.CrossRefGoogle Scholar
  8. 8.
    Díez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab. 2004;89:4890-4897.CrossRefPubMedGoogle Scholar
  9. 9.
    Doucet J, Trivalle C, Chassagne P, et al. Does age play a role in clinical presentation of hypothyroidism? J Am Geriatr Soc. 1994;42:984-986.PubMedGoogle Scholar
  10. 10.
    Davis JD, Tremont G. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinol. 2007;32:49-65.PubMedGoogle Scholar
  11. 11.
    Feldt-Rasmussen U. Treatment of hypothyroidism in elderly patients and in patients with cardiac disease. Thyroid. 2007;17:619-624.CrossRefPubMedGoogle Scholar
  12. 12.
    Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29:76-131.CrossRefPubMedGoogle Scholar
  13. 13.
    Tan ZS, Beiser A, Vasan RS, et al. Thyroid function and the risk of Alzheimer disease: the Framingham Study. Arch Intern Med. 2008;168:1514-1520.CrossRefPubMedGoogle Scholar
  14. 14.
    Biondi B. Cardiovascular effects of mild hypothyroidism. Thyroid. 2007;17:625-630.CrossRefPubMedGoogle Scholar
  15. 15.
    Ochs N, Auer R, Bauer DC, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008;148:832-845.PubMedGoogle Scholar
  16. 16.
    Razvi S, Shakoor A, Vanderpump M, Weaver JU, Pearce SH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab. 2008;93:2998-3007.CrossRefPubMedGoogle Scholar
  17. 17.
    Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292:2591-2599.CrossRefPubMedGoogle Scholar
  18. 18.
    van den Beld AW, Visser TJ, Feelders RA, Grobbee DE, Lamberts SW. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J Clin Endocrinol Metab. 2005;90:6403-6409.CrossRefPubMedGoogle Scholar
  19. 19.
    Sawin CT, Herman T, Molitch ME, London MH, Kramer SM. Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients. Am J Med. 1983;75:206-209.CrossRefPubMedGoogle Scholar
  20. 20.
    Trivalle C, Doucet J, Chassagne P, et al. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc. 1996;44:50-53.PubMedGoogle Scholar
  21. 21.
    Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med. 2005;118:706-714.CrossRefPubMedGoogle Scholar
  22. 22.
    Davis PJ, Davis FB. Hyperthyroidism in patients over the age of 60 years. Clinical features in 85 patients. Medicine. 1974;53:161-179.CrossRefPubMedGoogle Scholar
  23. 23.
    Tibaldi JM, Barzel US, Albin J, Surks M. Thyrotoxicosis in the very old. Am J Med. 1986;81:619-622.CrossRefPubMedGoogle Scholar
  24. 24.
    Nordyke RA, Gilbert FI, Harada ASM. Graves' Disease. Influence of age on clinical findings. Arch Intern Med. 1988;148:626-631.CrossRefPubMedGoogle Scholar
  25. 25.
    Martin FIR, Deam DR. Hyperthyroidism in elderly hospitalized patients. Clinical features and treatment outcomes. Med J Australia. 1996;164:200-203.PubMedGoogle Scholar
  26. 26.
    Lahey FH. Apathetic thyroidism. Ann Surg. 1931;93:1026.CrossRefPubMedGoogle Scholar
  27. 27.
    Sawin CT. Subclinical hyperthyroidism and atrial fibrillation. Thyroid. 2002;12:501-503.CrossRefPubMedGoogle Scholar
  28. 28.
    Martino E, Pacchiarotti A, Aghini-Lombardi F, et al. Serum free thyroxine in patients with T3-toxicosis. Acta Endocrinol (Copenhagen). 1985;110:354-359.Google Scholar
  29. 29.
    Wexler JA, Sharretts J. Thyroid and bone. Endocrinol Metab Clin North Am. 2007;36:673-705.CrossRefPubMedGoogle Scholar
  30. 30.
    Cooper DS, Doherty GM, Haugen BR, et al. The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109-142.CrossRefPubMedGoogle Scholar
  31. 31.
    Lin JD, Chao TC, Chen ST, Weng HF, Lin KD. Characteristics of thyroid carcinomas in aging patients. Eur J Clin Invest. 2000;30:147-153.CrossRefPubMedGoogle Scholar
  32. 32.
    Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE. National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab. 2007;92:4236-4240.CrossRefPubMedGoogle Scholar
  33. 33.
    Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005;90:5483-5488.CrossRefPubMedGoogle Scholar
  34. 34.
    Surks MI, Goswami G, Daniels GH. The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab. 2005;90:5489-5496.CrossRefPubMedGoogle Scholar
  35. 35.
    Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007;92:4575-4582.CrossRefPubMedGoogle Scholar
  36. 36.
    Hamilton TE, Davis S, Onstad L, Kopecky KJ. Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. J Clin Endocrinol Metab. 2008;93:1224-1230.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Division of EndocrinologyDiabetes, and Clinical Nutrition, Oregon Health & Science UniversityPortlandUSA

Personalised recommendations